Ligand Pharmaceuticals Incorporated (LGND) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 5.88B USD. 52-week range 175.89 to 326.63 USD. Trailing P/E 31.1. Data as of 2026-10-09.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also ...